Alfred Griffioen is a PhD candidate at Radboud University Medical Center in Nijmegen, the Netherlands. His research is about business models for prevention, with a focus on the role of private parties.
Investing in prevention, such as a gym subscription, dietary advice or smoke cessation coaching, is one of the best way to keep people healthy and reduce health care cost. But still, only 3% of all healthcare spending is on prevention. This is not caused by lack of research, over 5,000 studies per year are published on the effects of changing your behaviour, or your environment.
It would be great if not only governments invest in prevention, but also companies who can benefit from it: employers, insurers, health care providers. But with prevention, return on investment comes only after some time, and often scattered over various stakeholders. So how to solve this puzzle?
Alfred’s research concentrates on four questions:
- Does scientific research, and healthcare economic evaluations in particular, provide enough cause-and-effect data that companies can use to base a business case on?
- What is the role of research funders in the generation of this kind of information?
- What are benefit sharing or collaboration methodologies that private parties can use to jointly establish a positive business case for prevention?
- Which of these methodologies can easily be scales up internationally?
The questions follow the logic how a business case is built.
If you have any questions on this project, contact Alfred Griffioen on alfred.griffioen@radboudumc.nl